We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Silk-Based Technique Stabilizes Fluid Samples for Diagnostics or Research

By LabMedica International staff writers
Posted on 01 Jun 2016
Drying blood or other biological fluid samples together with silk fibroin has been suggested as an alternative to refrigeration or drying on paper for transporting specimens from the field to the laboratory.

Without proper temperature regulation, protein biomarkers in particular can degrade rapidly in blood samples, an effect that ultimately compromises the quality and reliability of laboratory tests. More...
Existing alternative collection and storage solutions, such as drying blood on paper cards, still fail to effectively protect biomarkers from heat and humidity.

Investigators at Tufts University (Medford, MA, USA) have described an alternative silk matrix encapsulation technique that overcomes these limitations and can be deployed using a simple air-drying approach. They mixed a solution or a powder of purified silk fibroin protein extracted from silkworm cocoons with blood or plasma and air-dried the mixture. The air-dried silk films were stored for up to 84 days at temperatures between 22 and 45 degrees Celsius. At set intervals, encapsulated blood samples were recovered by dissolving the films in water and analyzed.

Results revealed that the silk-based technique required accurate starting volumes of the blood or other specimens to be analyzed. Salts or other buffers were needed in some cases to reconstitute samples for accurate testing of certain markers. When these conditions were met, the investigators found that the silk fiber drying process was compatible with a number of immunoassays and provided enhanced sample preservation in comparison with traditional air-drying paper approaches.

"This approach should facilitate outpatient blood collection for disease screening and monitoring, particularly for underserved populations, and also serve needs of researchers and clinicians without access to centralized testing facilities. For example, this could support large-scale epidemiologic studies or remote pharmacological trials," said senior author Dr. David L. Kaplan, professor of biomedical engineering at Tufts University.

The process was described in detail in the May 9, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences.

Related Links:
Tufts University


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.